Table 1 Statistical summary of mapping resultsa.

From: Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through immune landscape analysis

Characteristic

AD

MCI

CN

Raw reads, n

42,851,964 ± 11,727,451

42,755,728 ± 12,595,261

44,883,385 ± 10,635,281

Q20, %

99.60 ± 0.47

99.53 ± 0.58

99.62 ± 0.44

Cleaned raw reads, n

42,378,025 ± 11,785,689

42,442,969 ± 12,532,294

44,241,452 ± 10,721,761

Unique mapped reads, %

82.54 ± 3.95

82.51 ± 3.85

82.77 ± 3.79

Multiple mapped reads, %

13.90 ± 3.68

14.05 ± 3.38

13.38 ± 3.49

  1. AD Alzheimer’s disease, MCI mild cognitive impairment, CN cognitively normal.
  2. aAll values are mean ± SD.